Inclusion Criteria:

• Subject must be 18 years of age or older
• Must have MGFA clinical classification Grades 2-4A at time of screening
• Subject must have clinically active disease and requiring ongoing therapy for GMG
• MG-ADL score 6 and QMG score >10 at screening
• GMG specific autoantibodies must be above the reference laboratory ULN

Exclusion Criteria:

• Subject is pregnant or breastfeeding
• Treatment with Anti-CD20 agents, calcineurin inhibitors, FcRN inhibitors, azathioprine, mycophenolate mofetil, methotrexate, or cyclophosphamide within the specified time frame prior to leukapheresis or prior to anito-cel infusion
• Previous treatment with any gene therapy, chimeric antigen receptor therapy or T cell engager
• Previous thymectomy within 6 months of screening
• Major chronic illness that is not well managed at the time of study entry and in the opinion of the investigator